Evidence map›Paper›PMID 42699082›Full record

ReviewiLIVER2026

Scorpion venom peptides: Novel therapeutic approaches for inflammatory and hepatic disorders.

Jwal Doctor, Zeal Parikh, Advaita Chauhan, Anirudh Raina

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in iLIVER, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jwal DoctorArnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, New York, NY, 11201, USA.
Zeal ParikhFaculty of Pharmacy, The Maharaja Sayajirao University of Baroda, Vadodara, 390001, India.
Advaita ChauhanArnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, New York, NY, 11201, USA.
Anirudh RainaArnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, New York, NY, 11201, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic hepatic disorders, such as metabolic dysfunction associated steatohepatitis (MASH), alcohol associated liver disease (ALD), and viral hepatitis (Hepatitis B virus [HBV]/Hepatitis C virus [HCV]), are primarily driven by persistent immune-mediated inflammation and hepatic stellate cell activation leading to fibrosis, yet conventional therapies lack tissue and molecular specificity. Scorpion venom peptides, refined through evolutionary selection, provide highly potent, target specific scaffolds capable of modulating intrahepatic inflammatory networks. Recent

Indexed as

Anti-inflammatory effectsGenomicsHepatic disordersScorpion venom peptidesTranscriptomics

Identifiers

PMID42699082
PMCPMC13543889

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.